Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | F2 | P00734 | 3/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 6/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.40 |
| ▸ | PLG | P00747 | 4/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | HPN | P05981 | 1/20 | 0.39 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9710680 | 0.90 | F10 (0.51) | F2PRSS1PLGF10HPN | |
| Hydrochloric Acid SCHEMBL9710621 | 0.84 | CA2 (0.51) | CA2F2ITGB3ITGA2BPRSS1 | |
| SCHEMBL9710523 | 0.84 | CA2 (0.50) | CA2F2ITGB3ITGA2BPRSS1 | |
| Hydrochloric Acid SCHEMBL9710624 | 0.80 | F2 (0.47) | CA2F2ITGB3ITGA2BPRSS1 | |
| SCHEMBL8954951 | 0.76 | PLG (0.51) | F2PLGF10HPN | |
| SCHEMBL9710492 | 0.75 | F10 (0.48) | F2PRSS1F10 | |
| Iodide SCHEMBL9710506 | 0.74 | F10 (0.48) | F2PRSS1F10 | |
| SCHEMBL9710610 | 0.74 | F10 (0.57) | F2PRSS1PLGF10 | |
| Hydrochloric Acid SCHEMBL9710860 | 0.74 | F10 (0.56) | F2PRSS1PLGF10 | |
| SCHEMBL9710389 | 0.74 | F2 (0.70) | F2ITGB3ITGA2BPLGF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992016549-A1 | PARASUBSTITUTED PHENYLALANINE DERIVATES | PENTAPHARM AG (CH) | 1992-10-01 | — | — | WO | disclosed |